201740-81-0
201740-81-0
Chemical Structure
L-Lysine-13C6 dihydrochloride
- CAS No.: 201740-81-0
- Formula:13C6H16Cl2N2O2
- Molecular Weight:225.07
IUPAC Name: L-lysine-13C6 dihydrochloride
InChIKey: JBBURJFZIMRPCZ-NHMLGGAVSA-N
SMILES: O=[13C](O)[13C@H]([13CH2][13CH2][13CH2][13CH2]N)N.Cl.Cl
Biological Activity: L-Lysine-13C6 (dihydrochloride) is the 13C-labeled L-Lysine dihydrochloride. L-lysine dihydrochloride is an essential amino acid[1][2] with important roles in connective tissues and carnitine synthesis, energy production, growth in children, and maintenance of immune functions[2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
L-Lysine-13C6 dihydrochloride | 99.83% | L-Lysine-13C6 (dihydrochloride) is the 13C-labeled L-Lysine dihydrochloride. L-lysine dihydrochloride is an essential amino acid with important roles in connective tissues and carnitine synthesis, energy production, growth in children, and maintenance of immune functions. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Lysine (Standard) | 99.94% | L-Lysine (Standard) is the analytical standard of L-Lysine. This product is intended for research and analytical applications. L-lysine is an essential amino acid for humans with orally activity. L-lysine can inhibit the occurrence of HSV infections and is used in herpes research. L-lysine increases calcium absorption, reduces diabetes-related diseases, improves gut health, and alleviates pancreatic inflammation. L-lysine can be used in research on metabolism, infection, and inflammation.
IC50 & Target:L-lysine (150 mg/kg) promotes, but not initiates, bladder cancer. The administration of L-lysine to rats submitted to colovesical cystoplasty accelerates the development of transitional metaplasia of the intestinal epithelium. L-lysine (10 mg/kg) treatment attenuates pancreatic tissue injury induced by L-arginine by inhibiting the release of the inflammatory cytokine IL-6 and enhance antioxidant activity. In Vivo:L-lysine (10?mg/kg, p.o., pre-treated or post-treated, administration duration 15 days) treatment attenuates pancreatic tissue injury induced by L-arginine by inhibiting the release of the inflammatory cytokine IL-6 and enhance antioxidant activity in acute pancreatitis mice model. L-lysine (5 or 10?mg/kg, p.o., 45 days) ameliorates sepsis-induced acute lung injury in a lipopolysaccharide (HY-D1056)-induced mouse model. |
||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Lysine-15N-1 dihydrochloride | 98.0% | L-Lysine-15N-1 (dihydrochloride) is the 15N-labeled L-Lysine. L-lysine is an essential amino acid with important roles in connective tissues and carnitine synthesis, energy production, growth in children, and maintenance of immune functions. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Lysine | 99.94% | L-lysine is an essential amino acid for humans with orally activity. L-lysine can inhibit the occurrence of HSV infections and is used in herpes research. L-lysine increases calcium absorption, reduces diabetes-related diseases, improves gut health, and alleviates pancreatic inflammation. L-lysine can be used in research on metabolism, infection, and inflammation. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
